MFIN compared with NAGE: revenue, margins and what each company keeps, and the suppliers and customers both name

MFINMedallion Financial Corp

Mkt capRevenueRevenue

NAGENiagen Bioscience, Inc.

Mkt capRevenueRevenue

Compare

MFINMedallion Financial Corp

NAGENiagen Bioscience, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

MFIN

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±15.5%▼−13.53%×0.87

Q2 FY26±15.0%▲+1.71%×0.11

Q1 FY26±18.1%▼−1.08%×0.06

Feb 19 '26±6.6%▼−1.98%×0.30

NAGE

2 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±12.6%▼−16.47%×1.31

Q2 FY26±27.5%▼−14.70%×0.53

= impliedMFIN realized, solidNAGE realized, hatchedOne scale, both sides: full bar = 28%× = |realized| ÷ impliedSource: market data

May 7 '26

±14.9%

▼−15.69%

×1.05

Q1 FY26±22.3%▲+3.24%×0.14

MFINMedallion Financial Corp

10.05▲+1.31%· post 10.01

Mkt cap$224.1MRevenue$62MQ3 FY26Revenue$248MFY25

NAGENiagen Bioscience, Inc.

2.07▼−1.90%· post 2.07

ClosedNov 6 '26

Mkt cap$163.9MRevenue$27MQ3 FY26Revenue$129MFY25

Compare

ClosedNov 6 '26

MFINMedallion Financial Corp

NAGENiagen Bioscience, Inc.

10.05▲+1.31%post 10.01

Price

2.07▼−1.90%post 2.07

$224.1M

Mkt cap

$163.9M

Q3 FY26$62M

Revenue

$27MQ3 FY26

FY25$248M

Revenue

$129MFY25

MFIN10.05▲+1.31%vsNAGE2.07▼−1.90%ClosedNov 6 '26